| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |